Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTSO Cytosorbents Corporation

盘前交易 05-02 08:27:26 EDT

1.01

+0.00

0.00%

盘前0.8000

-0.21-20.79%

08:27 EDT

最高1.07	最低1.00	成交量11.91万
今开1.02	昨收1.01	日振幅6.93%
总市值6,313万	流通市值5,516万	总股本6,250万
成交额12.38万	换手率0.22%	流通股本5,462万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTSO","market":"US","secType":"STK","nameCN":"Cytosorbents Corporation","latestPrice":1.01,"timestamp":1746129600000,"preClose":1.01,"halted":0,"volume":119054,"hourTrading":{"tag":"盘前","latestPrice":0.8,"preClose":1.01,"latestTime":"08:27 EDT","volume":48280,"amount":40123.441616000004,"timestamp":1746188832146},"delay":0,"floatShares":54615737,"shares":62500000,"eps":-0.380621,"marketStatus":"盘前交易","change":0,"latestTime":"05-02 08:27:26 EDT","open":1.02,"high":1.07,"low":1,"amount":123832.89899239999,"amplitude":0.069307,"askPrice":0.8684,"askSize":100,"bidPrice":0.784,"bidSize":149,"shortable":3,"etf":0,"ttmEps":-0.380621,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746192600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.01,"preHourTrading":{"tag":"盘前","latestPrice":0.8,"preClose":1.01,"latestTime":"08:27 EDT","volume":48280,"amount":40123.441616000004,"timestamp":1746188832146},"postHourTrading":{"tag":"盘后","latestPrice":0.9832,"preClose":1.01,"latestTime":"19:34 EDT","volume":52747,"amount":51504.1061,"timestamp":1746142479450},"volumeRatio":1.4971541801367834,"impliedVol":1.4591,"impliedVolPercentile":0.3092},"requestUrl":"/m/hq/s/CTSO/tweets","defaultTab":"tweets","newsList":[{"id":"2532884503","title":"Cytosorbents Corporation盘中异动 下午盘快速上涨5.94%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532884503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532884503?lang=zh_cn&edition=full","pubTime":"2025-05-02 02:41","pubTimestamp":1746124916,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日02时41分，Cytosorbents Corporation股票出现波动，股价快速上涨5.94%。截至发稿，该股报1.07美元/股，成交量6.1411万股，换手率0.10%，振幅5.95%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.06%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502024156a46f2e30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502024156a46f2e30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2531412055","title":"Cytosorbents Corporation盘中异动 早盘股价大跌6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531412055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531412055?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:56","pubTimestamp":1746021365,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时56分，Cytosorbents Corporation股票出现波动，股价大幅下挫6.25%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.60%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430215605aa2c7f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430215605aa2c7f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2530745130","title":"Cytosorbents Corporation盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530745130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530745130?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:51","pubTimestamp":1745589112,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时51分，Cytosorbents Corporation股票出现波动，股价急速下跌5.03%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.20%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425215152a466e767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425215152a466e767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2512480345","title":"Cytosorbents Corporation股价飙升10.17% 市值涨284.37万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512480345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512480345?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:33","pubTimestamp":1739986437,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时33分，Cytosorbents Corporation股票出现异动，股价急速拉升10.17%。截至发稿，该股报1.30美元/股，成交量4.6002万股，换手率0.08%，振幅3.81%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.49%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200133579628eae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200133579628eae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2512165553","title":"Cytosorbents Corporation盘中异动 早盘快速跳水10.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165553?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889138,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Cytosorbents Corporation股票出现波动，股价大幅跳水10.77%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.85%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232189889fcbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232189889fcbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2511941706","title":"Cytosorbents Corporation盘中异动 早盘大幅下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511941706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511941706?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:07","pubTimestamp":1739545633,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时07分，Cytosorbents Corporation股票出现波动，股价大幅跳水5.34%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.06%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214230713abcf0ea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214230713abcf0ea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2511658385","title":"Cytosorbents Corporation盘中异动 股价大涨5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511658385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511658385?lang=zh_cn&edition=full","pubTime":"2025-02-13 01:48","pubTimestamp":1739382487,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日01时48分，Cytosorbents Corporation股票出现波动，股价急速上涨5.64%。截至发稿，该股报1.13美元/股，成交量5.3507万股，换手率0.09%，振幅4.67%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.46%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213014808abcc88d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213014808abcc88d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2510335029","title":"Cytosorbents Corporation盘中异动 早盘大幅上涨5.04%报1.040美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510335029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510335029?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:27","pubTimestamp":1739287662,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时27分，Cytosorbents Corporation股票出现异动，股价急速拉升5.04%。截至发稿，该股报1.040美元/股，成交量3.5116万股，换手率0.06%，振幅6.06%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.26%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232742961f52bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232742961f52bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2509208263","title":"Cytosorbents Corporation盘中异动 早盘股价大涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509208263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509208263?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:43","pubTimestamp":1738856593,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时43分，Cytosorbents Corporation股票出现异动，股价大幅上涨5.94%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.19%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234313abc4e4a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206234313abc4e4a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2503916421","title":"Cytosorbents Corporation盘中异动 急速跳水5.56%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503916421?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:11","pubTimestamp":1737040314,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时11分，Cytosorbents Corporation股票出现异动，股价大幅跳水5.56%。截至发稿，该股报1.02美元/股，成交量3.1816万股，换手率0.06%，振幅5.09%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.93%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116231154abad5983&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116231154abad5983&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2503776615","title":"Cytosorbents Corporation盘中异动 股价大涨5.71%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503776615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503776615?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:36","pubTimestamp":1736865380,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时36分，Cytosorbents Corporation股票出现波动，股价大幅拉升5.71%。截至发稿，该股报1.11美元/股，成交量1.4859万股，换手率0.03%，振幅2.28%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.70%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223620a221b9b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223620a221b9b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2503801586","title":"Cytosorbents Corporation盘中异动 早盘股价大涨6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503801586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503801586?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:57","pubTimestamp":1736780242,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时57分，Cytosorbents Corporation股票出现异动，股价快速拉升6.64%。截至发稿，该股报1.000美元/股，成交量2.1137万股，换手率0.04%，振幅6.40%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.27%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132257229864dad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132257229864dad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2502898777","title":"Cytosorbents Corporation盘中异动 快速跳水5.14%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502898777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502898777?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:20","pubTimestamp":1736522415,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时20分，Cytosorbents Corporation股票出现异动，股价快速跳水5.14%。截至发稿，该股报0.920美元/股，成交量2.1578万股，换手率0.04%，振幅5.15%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.34%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110232015aba60f73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110232015aba60f73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2501783923","title":"Cytosorbents Corporation盘中异动 早盘急速下跌5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501783923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501783923?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:02","pubTimestamp":1736262159,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日23时02分，Cytosorbents Corporation股票出现波动，股价大幅下跌5.76%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.13%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107230239a218eebe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107230239a218eebe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2501230165","title":"Cytosorbents Corporation盘中异动 股价大涨7.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501230165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501230165?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:31","pubTimestamp":1736173913,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时31分，Cytosorbents Corporation股票出现波动，股价快速上涨7.84%。截至发稿，该股报1.010美元/股，成交量18.4445万股，换手率0.34%，振幅0.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.13%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223154985ce758&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106223154985ce758&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2500142061","title":"Cytosorbents Corporation盘中异动 早盘股价大跌5.43%报0.870美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500142061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500142061?lang=zh_cn&edition=full","pubTime":"2025-01-03 22:30","pubTimestamp":1735914641,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日22时30分，Cytosorbents Corporation股票出现异动，股价大幅跳水5.43%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.00%。其相关个股中，Quantum-Si Incorporated、Strata Skin Sciences, Inc.、Envveno Medical Corporation涨幅较大，Quantum-Si Incorporated、Cytosorbents Corporation、Adagio Medical Holdings, Inc较为活跃，换手率分别为18.59%、9.18%、1.18%，振幅较大的相关个股有Ainos, Inc.、阿尔法泰克、古特拉，振幅分别为4.00%、2.10%、1.79%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223042985a3d4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103223042985a3d4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2495615744","title":"Cytosorbents Corporation盘中异动 股价大涨5.56%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495615744","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495615744?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:47","pubTimestamp":1735656422,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时47分，Cytosorbents Corporation股票出现波动，股价急速上涨5.56%。截至发稿，该股报0.950美元/股，成交量1.4259万股，换手率0.03%，振幅5.56%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.39%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231224702a2108e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231224702a2108e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2494670408","title":"Cytosorbents Corporation盘中异动 股价大涨5.23%报0.940美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494670408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494670408?lang=zh_cn&edition=full","pubTime":"2024-12-27 00:37","pubTimestamp":1735231031,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日00时37分，Cytosorbents Corporation股票出现异动，股价急速上涨5.23%。截至发稿，该股报0.940美元/股，成交量5.0478万股，换手率0.09%，振幅7.38%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.07%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227003711a20aafdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227003711a20aafdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2493087928","title":"Cytosorbents Corporation盘中异动 早盘急速拉升9.72%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493087928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493087928?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:32","pubTimestamp":1735050779,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时32分，Cytosorbents Corporation股票出现波动，股价急速上涨9.72%。截至发稿，该股报0.920美元/股，成交量6095股，换手率0.01%，振幅0.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.16%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。该公司的产品包括Cytosorb、ECOS-300CY、VetResQ、HemoDefend和DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223259a207c0b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223259a207c0b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2493977347","title":"Cytosorbents Corporation盘中异动 快速跳水6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493977347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493977347?lang=zh_cn&edition=full","pubTime":"2024-12-24 03:56","pubTimestamp":1734983806,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日03时56分，Cytosorbents Corporation股票出现异动，股价大幅下挫6.24%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.05%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门在重症监护和心脏手术中运用专有的聚合物吸附技术治疗危及生命的疾病。其旗舰产品CytoSorb在欧盟被批准为体外细胞因子吸收剂，旨在减少炎症和预防脓毒症和创伤等危重疾病的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224035646984d3f42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224035646984d3f42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytosorbents.com","stockEarnings":[{"period":"1week","weight":-0.1293},{"period":"1month","weight":0.01},{"period":"3month","weight":0.005},{"period":"6month","weight":0.01},{"period":"1year","weight":0.2014},{"period":"ytd","weight":0.1099}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.0045},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1162},{"period":"ytd","weight":-0.0471}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cytosorbents Corporation于2002年4月25日在内华达州注册成立。该公司是重症监护运用血液净化调节炎症的集中免疫治疗公司，以预防或治疗危及生命的多器官衰竭为目标。该技术是基于生物相容的，高度多孔的聚合物吸附剂的珠子，其能够提取血液和其它体液中不需要的物质。该技术是受32项美国专利的保护。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.086963},{"month":2,"riseRate":0.818182,"avgChangeRate":0.104089},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.036736},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.069534},{"month":5,"riseRate":0.363636,"avgChangeRate":0.033786},{"month":6,"riseRate":0.6,"avgChangeRate":0.014902},{"month":7,"riseRate":0.8,"avgChangeRate":0.112969},{"month":8,"riseRate":0.5,"avgChangeRate":-0.045951},{"month":9,"riseRate":0.4,"avgChangeRate":0.00706},{"month":10,"riseRate":0.2,"avgChangeRate":-0.063548},{"month":11,"riseRate":0.3,"avgChangeRate":-0.070743},{"month":12,"riseRate":0.2,"avgChangeRate":-0.07363}],"exchange":"NASDAQ","name":"Cytosorbents Corporation","nameEN":"Cytosorbents"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cytosorbents Corporation(CTSO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cytosorbents Corporation,CTSO,Cytosorbents Corporation股票,Cytosorbents Corporation股票老虎,Cytosorbents Corporation股票老虎国际,Cytosorbents Corporation行情,Cytosorbents Corporation股票行情,Cytosorbents Corporation股价,Cytosorbents Corporation股市,Cytosorbents Corporation股票价格,Cytosorbents Corporation股票交易,Cytosorbents Corporation股票购买,Cytosorbents Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cytosorbents Corporation(CTSO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}